Cite
HARVARD Citation
Tohyama, O. et al. (2014). Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models. Journal of thyroid research. p. . [Online].